Publication | Open Access
A Phase 2 Study of Actinium-225 (225Ac)-lintuzumab in Older Patients with Untreated Acute Myeloid Leukemia (AML)
23
Citations
0
References
2019
Year
Hematological MalignancyOlder PatientsMedicineMixed-phenotype Acute LeukemiaHematologyImmunologyPathologyPhase 2Adult T-cell Leukemia-lymphomaOncologyCancer ResearchTumor BiologyMyeloid Neoplasia
No additional data available for this publication yet. Check back later!